
Glivin PM 1mg/500mg/15mg Tablet SR
Marketer
Aeon Remedies
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glivin PM 1mg/500mg/15mg Tablet SR
Glimepiride-Metformin-Pioglitazone extended-release tablets (1mg/500mg/15mg) are a triple-combination medication designed to manage elevated blood glucose. This formulation, used alongside diet and exercise, enhances glycemic control in adult patients with type 2 diabetes. It improves insulin effectiveness, consequently reducing blood sugar. Dosage and frequency of Glimepiride-Metformin-Pioglitazone should strictly adhere to your physician's instructions. Administer this medication with food to minimize gastrointestinal discomfort. If a dose is missed, take it immediately; however, if the next dose is imminent, omit the missed dose and resume the regular schedule. Never double the dose. Overdosage can cause dangerously low blood sugar (hypoglycemia). Concomitant use with other antidiabetic agents, alcohol consumption, or meal skipping may increase the risk of hypoglycemia. Regular blood glucose monitoring is crucial during treatment. Frequently reported adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to initiating therapy, inform your doctor of any existing kidney, liver, or heart conditions. Pregnant or lactating individuals should seek medical advice before using this medication. Renal function tests will be performed before treatment commences. Limit alcohol consumption as it may heighten the likelihood of adverse reactions.
Primary Ingredients of Glivin PM 1mg/500mg/15mg Tablet SR
No information provided. Please provide the text you wish me to rephrase.
Uses of Glivin PM 1mg/500mg/15mg Tablet SR
Managing Type 2 Diabetes
Major Benefits of Glivin PM 1mg/500mg/15mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or fracturing it. Consume the Glivin PM 1mg/500mg/15mg Sustained-Release Tablet with food.
Common Side effects of Glivin PM 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glivin PM 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet; do not crush, chew, or fracture it. Glivin PM 1mg/500mg/15mg Extended-Release tablets should be administered with a meal.
How Glivin PM 1mg/500mg/15mg Tablet SR works:
Glivin PM 1mg/500mg/15mg Extended-Release Tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple therapy improves blood sugar management when single or dual medications prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Finally, pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glivin PM 1mg/500mg/15mg SR tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glivin PM 1mg/500mg/15mg SR tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Consult your doctor for advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glivin PM 1mg/500mg/15mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glivin PM 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician. This medication is contraindicated in those with severe kidney disease. Kidney function should be regularly monitored during treatment.
LiverCAUTION
Patients with liver impairment should use Glivin PM 1mg/500mg/15mg SR tablets cautiously, as dose modification may be necessary. Individuals with severe hepatic dysfunction should avoid this medication. Physician consultation is advised.
What if you forget to take Glivin PM 1mg/500mg/15mg Tablet SR :
Should you forget to take your Glivin PM 1mg/500mg/15mg Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glivin PM 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
